Every practice buyer asks me the same question first: how much cash do I actually need to bring to closing? There’s no flat percentage I can hand you, because a practice acquisition equity injection isn’t a fixed rulebook number — it’s a figure that moves with the strength of the practice, the structure of the deal, and how the lender views the risk in front of them. In my experience, buyers who understand what’s driving that number end up negotiating better and getting to closing faster than the ones who just chase a round percentage they heard from a colleague.
What a Practice Acquisition Equity Injection Actually Buys You
Think of your equity injection as the cushion that makes a lender comfortable financing the rest. It’s not just a hoop to jump through — it demonstrates you have skin in the game and some ability to absorb a rough first year without the whole deal falling apart. Lenders who finance practice purchases are underwriting a business with real cash flow volatility built in: patient attrition after a transition, a producing owner stepping back, insurance contracts that may need renegotiating. A meaningful practice acquisition equity injection tells the underwriter you’re not walking away at the first bump in collections.
That said, “meaningful” is doing a lot of work in that sentence, and it looks different for a solo dental practice in Sacramento than it does for a multi-provider veterinary group buy-in in Denver. I’ve seen strong files get financed with less cash down than a shaky file with more — the injection amount is one input among several, not the whole story.
Why the Equity Injection Amount Varies by Transaction
If you’ve talked to more than one lender, you’ve probably already noticed the numbers don’t match. That’s normal, and it’s not a sign someone’s giving you a bad quote. A few things move the needle on any practice acquisition equity injection:
- Purchase structure — an outright buyout, a partial buy-in, or an associate-to-owner transition each carry different risk profiles and different equity expectations.
- Collections trend — a practice with three years of flat or growing collections generally supports a smaller injection than one with a recent dip, even if the trailing twelve months look fine on paper.
- Payer mix — heavy reliance on a narrow set of insurance contracts or a single referral source reads as concentration risk, and lenders often want more buyer cash to offset that.
- Seller transition length and terms — a seller staying on for a real transition period, or carrying a note themselves, can soften what the lender asks of you.
- Whether real estate is part of the purchase — buying the building alongside the practice changes both the loan size and the collateral picture, which affects the equity conversation.
None of this is arbitrary. Underwriters are weighing your credit history, the practice’s cash flow, and the deal structure together — no single factor guarantees a particular equity requirement, and I’d be doing you a disservice if I told you otherwise. If you want the mechanics of how that cash flow gets calculated in the first place, our piece on how lenders handle practice cash flow underwriting walks through it in more detail.
Collections, Payer Mix, and Valuation Drive the Number
The practice’s own numbers do more to set your equity injection than any generic industry rule. Valuation matters here too — if the purchase price is running ahead of what the practice’s cash flow can reasonably support, a lender may lean on a larger buyer contribution to close that gap rather than stretch the loan amount. That’s part of why I always tell buyers to get a real look at what a practice is worth before they fall in love with a number the seller’s broker put on a listing sheet.
Add-backs are another spot where I see deals get delayed. Sellers (and sometimes their CPAs) will present adjusted EBITDA with generous add-backs for personal expenses, one-time costs, or owner perks. Lenders don’t automatically accept all of it — some add-backs hold up, some don’t, and the gap between the seller’s adjusted number and the lender’s accepted number can directly affect how much equity you need to bridge the difference. It’s worth reading through what actually counts as a practice add-back before you build your offer around someone else’s spreadsheet.
Documenting the Source of Your Funds
Bringing the cash isn’t the finish line — you also need to show where it came from, and this is where I see otherwise-smooth deals stall out. Lenders generally want to see a clean paper trail for your practice acquisition equity injection: recent bank statements showing the funds seasoned in your account, a clear explanation for any large or unusual deposits, and documentation if any portion is a gift or loan from family. If retirement funds or a business partner’s contribution are part of the mix, expect additional paperwork tying that money back to a legitimate, verifiable source.
A few practical habits that save time later:
- Avoid moving money between accounts right before you apply — it creates a trail underwriters have to chase down.
- If a family member is gifting part of your injection, get a signed gift letter drafted early rather than scrambling for one during underwriting.
- Keep statements for any account you’ll draw from, going back several months, even if you don’t think you’ll need all of them.
If gift funds are involved, it’s worth understanding the tax-side reporting requirements too — the IRS’s guidance on gift tax reporting is a useful reference for the giver, separate from whatever your lender requires for verification.
Not sure how a practice acquisition equity injection would work in your specific deal? Take a look at our practice financing options for dental, medical, and veterinary buyers and let’s talk through your numbers.
When Real Estate Is Part of the Deal
Buying the building along with the practice — common in dental and veterinary transitions especially — changes the equity conversation again. Real estate typically brings more collateral value to the deal, which can offset some of the risk a lender sees in the operating business itself. But it also means a bigger total loan amount and, often, a separate look at the property’s condition and market value. If a straightforward business acquisition loan isn’t the right fit once real estate enters the picture, an SBA-backed structure is frequently the better tool for combining the business and the building — you can see how that works on our SBA 504 & 7(a) loan page.
For buyers weighing multiple financing paths side by side, our overview of how a practice purchase gets funded is a good next stop before you commit to a structure.
FAQ: Practice Acquisition Equity Injection
Can I use borrowed money for my equity injection?
Sometimes, though it depends on the lender and the source. Funds borrowed against other collateral you own are viewed differently than an unsecured personal loan, and any borrowed portion still needs to be documented and disclosed as part of your application.
Does a longer seller transition reduce how much cash I need?
It can be one factor that helps, since it lowers perceived transition risk — but it’s weighed alongside collections trends, payer mix, and valuation, not a substitute for them.
Is the equity injection the same as my closing costs?
No. Your injection is separate from — and in addition to — transaction costs like appraisal fees, legal fees, and any lender fees, so budget for both when you’re planning cash on hand.
Thinking about your next move? Get a fast, no-pressure look at your options with a licensed Loanatik officer. Start here →
This article is general education, not financial advice or a commitment to lend. Loan programs, terms, and availability are subject to credit approval and may change. Loanatik LLC is an Equal Housing Lender. See our licensing & disclosures.
